書誌事項
- タイトル別名
-
- Combined MTX-5FU-CBDCA for the Treatment of Head and Neck Cancer.
この論文をさがす
抄録
Combination chemotherapy including 5FU and carboplatin (CBDCA) with methotrexate (MTX) and leucovorin (LV) as biochemical modulation was performed on patients with head and neck cancer. A total of 32 patients were treated in the order of MTX, continuous 5FU infusion and LV injection, CBDCA. 24 of the 32 patients were concurrently treated with radiation therapy. Treatment-associated toxicity was significant, including mucositis, myelosuppression and body weight losses, but they were within acceptable limits. The 5-year survival rates calculated using Kaplan-Meyer methods were 41.3%.
収録刊行物
-
- 耳鼻咽喉科臨床
-
耳鼻咽喉科臨床 95 (1), 81-85, 2002
耳鼻咽喉科臨床学会
- Tweet
詳細情報
-
- CRID
- 1390282679235923840
-
- NII論文ID
- 10008098721
-
- NII書誌ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可